e-Nicotine Technology’s Executive Management Team Leading Talks on Innovation in Nicotine Delivery at a Wide Variety of Regulatory and Industry Conferences

e-Nicotine Technology (eNT) today announced that members of its executive management team will be speaking at a variety of important industry conferences this spring, including: the FDA’s Center for Tobacco Products Tobacco Products Scientific Advisory Committee (TPSAC) meeting on April 16th (Rockville, MD), the Tobacco Merchants Association on May 21st (Williamsburg, VA), and the e-Cig Conference on June 18th (Nice, France).

Michael Hufford, Ph.D., eNT’s Co-Founder and Chief Medical Officer, presented to the FDA’s Center for Tobacco Products’ TPSAC meeting on April 16th. His talk focused on innovation in nicotine delivery and slides of the presentation can be viewed online at http://1.usa.gov/RPQlfS. On May 21st, Dr. Hufford will be part of a panel discussion on “The Evolving Nicotine Consumer” at the Tobacco Merchants Association, an annual conference of public health experts, scientists, regulators, wholesalers, retailers, and importers, as well as electronic cigarette companies.

Jeff Williams, eNT’s Co-Founder and Chief Executive Officer, will be presenting at the e-Cig Europe conference on June 18th. His talk, entitled “The Next Generation of Nicotine Delivery Systems”, will focus on how eNT’s delivery platform gives smokers a satisfying nicotine experience while helping them transition off of combustible cigarettes. Results from eNT’s recently completed Phase 1 clinical study will also be reviewed, which found that the eNT nicotine aerosol reduced smoking urges by over 70% within 1-minute, setting a new standard for smoking urge relief. eNT’s form factor is unique and does not try to mimic traditional combustible cigarettes, such as those from British American Tobacco (NYSEMKT:BTI), Lorillard (NYSE:LO), Phillip Morris (NYSE:PM), and Reynolds American (NYSE:RAI). Existing electronic cigarettes such as NJOY, blu eCigs (NYSE:LO), MarkTen (NYSE:MO), and Victory electronic cigarettes (OTCMKTS:ECIG) rely on a form factor that imitates a combustible cigarette.

About e-Nicotine Technology

eNT is a healthcare company committed to reducing the harms associated with combustible tobacco products. eNT is developing the next generation of state-of-the-art electronic nicotine delivery products that quickly and dramatically reduce smoking urge while using 40-70% less nicotine than cigarettes or existing e-cigarettes. eNT’s products deliver consistent doses of nicotine and emit no secondhand vapor, giving consumers a discreet and satisfying nicotine experience anytime, anywhere.

For more information about eNT, its technology, products and other inquiries, please contact: Justin Bingham, VP Corporate Development at +1.801.502.3458 or jbingham@enicotinetechnology.com.